Related Experiment Video
Updated: Jun 24, 2025
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Notable surgical trials in gynecologic oncology: a 10-year overview
José C Vilches1, María Clara Santía2, Elise Mann Yates2
1Department of Obstetrics and Gynecology, Hospital Quironsalud Malaga, Malaga, Spain jcvilches@sego.es.
Abstract:
In the last decade, we have witnessed important advances in novel therapeutics in the management of gynecologic cancers. These studies have built on the findings from preexisting data and have provided incremental contributions leading to changes that have not only impacted the accuracy of cancer detection and its metastatic components but also led to improvements in oncologic outcomes and quality of life. Key landmark trials have changed the standard of care in cervix, uterine, and ovarian cancer. A number of these have been controversial and have generated significant debate among gynecologic oncologists. The main objective of this review was to provide an overview on each of these trials as a reference for immediate and consolidated access to the study aims, methodology, results, and conclusion.
Insights
Recent advances in gynecologic cancer therapeutics have improved detection and outcomes. Landmark trials in cervical, uterine, and ovarian cancers have changed standards of care, sparking debate among oncologists.
Area of Science:
- Gynecology
- Oncology
- Therapeutics
Background:
- Significant advances in novel therapeutics for gynecologic cancers have emerged in the past decade.
- These advancements build upon existing data, improving cancer detection, metastasis assessment, and patient outcomes.
- Landmark clinical trials have notably altered the standard of care for cervical, uterine, and ovarian cancers.
Purpose of the Study:
- To review key landmark trials in gynecologic oncology.
- To provide consolidated access to the aims, methodology, results, and conclusions of these pivotal studies.
- To serve as a reference for understanding recent therapeutic changes and ongoing debates in the field.
Main Methods:
- Comprehensive literature review of landmark clinical trials in gynecologic cancer management.
- Analysis of trial data focusing on study design, therapeutic interventions, and outcomes.
- Synthesis of findings to highlight changes in the standard of care and areas of controversy.
Main Results:
- Identified key trials that have significantly impacted the management of cervix, uterine, and ovarian cancers.
- Documented improvements in oncologic outcomes and quality of life attributable to novel therapeutics.
- Highlighted controversial aspects of certain trials that have generated substantial discussion among experts.
Conclusions:
- Novel therapeutics and landmark trials have led to significant progress in gynecologic cancer care.
- Ongoing evaluation and debate surrounding these trials are crucial for refining future treatment strategies.
- This review provides a valuable resource for clinicians and researchers navigating the evolving landscape of gynecologic oncology.
More Related Videos
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
05:16Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
